Profund Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-13,942
| Closed | -$207K | – | 1336 |
|
|
2019
Q2 | $207K | Sell |
13,942
-1,640
| -11% | -$24.3K | 0.01% | 1125 |
|
|
2019
Q1 | $387K | Buy |
15,582
+60
| +0.4% | +$1.49K | 0.02% | 768 |
|
|
2018
Q4 | $279K | Sell |
15,522
-3,974
| -20% | -$71.4K | 0.02% | 798 |
|
|
2018
Q3 | $573K | Buy |
19,496
+1,692
| +10% | +$49.7K | 0.02% | 702 |
|
|
2018
Q2 | $810K | Buy |
17,804
+227
| +1% | +$10.3K | 0.03% | 473 |
|
|
2018
Q1 | $928K | Sell |
17,577
-1,686
| -9% | -$89K | 0.04% | 446 |
|
|
2017
Q4 | $1.31M | Sell |
19,263
-2,015
| -9% | -$137K | 0.05% | 351 |
|
|
2017
Q3 | $1.75M | Buy |
+21,278
| New | +$1.75M | 0.07% | 250 |
|
|
2016
Q3 | – | Sell |
-19,227
| Closed | -$264K | – | 1483 |
|
|
2016
Q2 | $264K | Sell |
19,227
-502
| -3% | -$6.89K | 0.01% | 1206 |
|
|
2016
Q1 | $379K | Sell |
19,729
-4,630
| -19% | -$88.9K | 0.02% | 925 |
|
|
2015
Q4 | $853K | Buy |
24,359
+254
| +1% | +$8.9K | 0.04% | 422 |
|
|
2015
Q3 | $2.22M | Buy |
+24,105
| New | +$2.22M | 0.13% | 114 |
|